Titelia

Holdings of Seven Fleet Capital Management LP

89 declared positions · as of Mar 31, 2026

Original filing · Ten largest lines: 43.4 % of the equity sleeve

Sector breakdown

  • Health care 0.8 %
  • Unattributed 99.2 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • US 92.7 %
  • FR 3.6 %
  • DK 1.7 %
  • GB 1.1 %
  • KY 0.9 %

Shares computed on the equity sleeve.

RankCountryLinesValueShare
1US83150M $92.67 %
2FR25.9M $3.65 %
3DK12.8M $1.72 %
4GB21.7M $1.05 %
5KY11.5M $0.91 %

Positions

RankCompanySharesValueWeight
1Tango Therapeutics Inc 502,01210.5M $
2Revolution Medicines Inc 80,7927.9M $
3Tyra Biosciences Inc 195,6857.5M $
4Liquidia Corp 187,8767.1M $
5Agios Pharmaceuticals Inc 209,5477.1M $
6Century Therapeutics Inc 2,947,8266.7M $
7Enliven Therapeutics Inc 164,0306.4M $
8Vaxcyte Inc 108,4506.3M $
9Cogent Biosciences Inc 149,3995.8M $
10CG oncology Inc 75,7585.1M $
11Abivax SA 43,0524.8M $
12Dianthus Therapeutics Inc 54,2584.6M $
13Cytokinetics Inc 61,2694M $
14Soleno Therapeutics Inc 115,7703.9M $
15Erasca Inc 222,4683.6M $
16AVALO THERAPEUTICS INC 213,8193.2M $
17Ideaya Biosciences Inc 86,2832.9M $
18Taysha Gene Therapies Inc 625,7082.8M $
19Ascendis Pharma A/S 12,1792.8M $
20Compass Therapeutics Inc 516,9722.7M $
21DAMORA THERAPEUTICS INC 101,2482.6M $
22KalVista Pharmaceuticals Inc 128,4872.6M $
23Relay Therapeutics Inc 257,7382.6M $
24Axsome Therapeutics Inc 14,0552.4M $
25Mineralys Therapeutics Inc 69,5711.9M $
26Madrigal Pharmaceuticals Inc 3,3931.8M $
27CytomX Therapeutics Inc 371,3981.7M $
28LeonaBio Inc 164,6761.7M $
29Savara Inc 295,6881.6M $
30Perspective Therapeutics Inc 379,0821.6M $
31Assembly Biosciences Inc 56,1471.6M $
32Minerva Neurosciences Inc 248,4761.5M $
33ZAI LAB LTD 77,8581.5M $
34Tarsus Pharmaceuticals Inc 19,8001.4M $
35Corvus Pharmaceuticals Inc 82,8901.2M $
36ArriVent Biopharma Inc 50,2521.2M $
37Larimar Therapeutics Inc 256,5851.2M $
38Krystal Biotech Inc 4,3161.1M $
39Inventiva SACA 200,1411.1M $
40Lipocine Inc 124,942998.3K $
41Spyre Therapeutics Inc 19,690993.2K $
42BioCryst Pharmaceuticals Inc 102,493975.7K $
43Xencor Inc 80,000964.8K $
44Celldex Therapeutics Inc 29,300929.4K $
45Replimune Group Inc 120,400921.1K $
46Maze Therapeutics Inc 30,707916.6K $
47Climb Bio Inc 130,654895K $
48Compass Pathways plc 158,021873.9K $
49Silence Therapeutics PLC 156,759826.1K $
50Corbus Pharmaceuticals Holdings Inc 85,687804.6K $
51Celcuity Inc 6,000684.8K $
52AN2 Therapeutics Inc 199,701683K $
53Denali Therapeutics Inc 35,286677.5K $
54United Therapeutics Corp 1,128668.9K $
55Eli Lilly & Co 720662.2K $
56Verastem Inc 123,400654K $
57Geron Corp 424,180632K $
58Opus Genetics Inc 134,242610.8K $
59Inhibikase Therapeutics Inc 325,600547K $
60Context Therapeutics Inc 190,785499.9K $
61Voyager Therapeutics Inc 115,203444.7K $
62Structure Therapeutics Inc 9,000433.8K $
63Protagonist Therapeutics Inc 4,000421.6K $
64Intellia Therapeutics Inc 31,500403.8K $
65SAB Biotherapeutics Inc 100,000383K $
66Palisade Bio Inc 213,100372.9K $
67Monte Rosa Therapeutics Inc 22,530370.6K $
68Edgewise Therapeutics Inc 11,701368.6K $
69Unicycive Therapeutics Inc 55,700366.5K $
70Contineum Therapeutics Inc 27,054353.3K $
71Trevi Therapeutics Inc 27,149323.9K $
72Evolus Inc 78,057320.8K $
73Nektar Therapeutics 4,300309.4K $
74Fulcrum Therapeutics Inc 38,100292.2K $
75Septerna Inc 11,445275K $
76Ocular Therapeutix Inc 31,296265.1K $
77Zentalis Pharmaceuticals Inc 110,000257.4K $
78Amylyx Pharmaceuticals Inc 16,671231.7K $
79Nuvalent Inc 2,072212.3K $
80Beam Therapeutics Inc 8,804209.8K $
81Disc Medicine Inc 3,231206.6K $
82Aadi Bioscience Inc 54,296187.3K $
83Inhibrx Biosciences Inc 2,482166.9K $
84Apogee Therapeutics Inc 1,969165.7K $
85C4 Therapeutics Inc 57,076150.1K $
86PepGen Inc 59,500105.3K $
87PMV Pharmaceuticals Inc 63,49878.7K $
88MacroGenics Inc 13,38738.7K $
89Cullinan Therapeutics Inc 1,84426.2K $